APA (7th ed.) Citation

De Moura, A., Gleizes, O., Cabel, L., Bethune-Volters, A., Bellesoeur, A., Bello-Roufai, D., . . . Genevée, T. (2025). Efficacy and toxicity of post-neoadjuvant trastuzumab emtansine in HER2-positive breast cancer patients treated at Institut Curie Hospitals. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-24849-0

Chicago Style (17th ed.) Citation

De Moura, Alexandre, et al. "Efficacy and Toxicity of Post-neoadjuvant Trastuzumab Emtansine in HER2-positive Breast Cancer Patients Treated at Institut Curie Hospitals." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-24849-0.

MLA (9th ed.) Citation

De Moura, Alexandre, et al. "Efficacy and Toxicity of Post-neoadjuvant Trastuzumab Emtansine in HER2-positive Breast Cancer Patients Treated at Institut Curie Hospitals." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-24849-0.